The trademark application NEUROLIEF was filed by Neurolief Ltd., a corporation established under the laws of the State of Israel (the "Applicant"). The application was published for oppositions on March 29, 2022, and it was registered by office on July 6, 2022 without any oppositions.
The application was filed in English (Spanish was selected as the second language).
Goods And Services
The mark was filed in class 9 with following description of goods:
Software for use in the treatment of chronic neurological and neuropsychiatric disorders
Platform software for distributing the treatment of chronic neurological and neuropsychiatric disorders to users
Software for analysing signals measured from the brain for treatment purposes.
The mark was filed in class 10 with Medical apparatus, namely, electrical stimulation apparatus for the head and brain for therapeutic purposes and Apparatus for measuring and analysing signals from the brain for medical purposes..
The mark was filed in class 42 with following description of goods:
Research and development in the field of medical devices, namely, medical devices for use in the treatment of chronic neurological and neuropsychiatric disorders
Research and development of software for use in the treatment of chronic neurological and neuropsychiatric disorders
Development and design of mobile applications for use in the treatment of chronic neurological and neuropsychiatric disorders.